Krainer Adrian R.
SEC Form 4 insider trading activity
Krainer Adrian R. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Mar 12, 2026.
On the most recent filing, Krainer Adrian R. is listed as Director at Stoke Therapeutics, Inc. Inside the rolling window, Krainer Adrian R. reported no open-market purchases and 4 open-market sales totaling $3.9M in STOK. The largest disclosed transaction in the window is a sale of 33,243 STOK shares on Mar 10, 2026, worth $1.3M.
Companies traded
Other insiders at STOK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Krainer Adrian R. made?
Krainer Adrian R. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Krainer Adrian R. trade?
Krainer Adrian R. has filed SEC Form 4 disclosures for 1 company, including STOK.
When was Krainer Adrian R.'s most recent SEC Form 4 filing?
Krainer Adrian R.'s most recent SEC Form 4 filing on Tracefour is dated Mar 12, 2026.
What is Krainer Adrian R.'s total buy and sell value in the current window?
Inside the rolling retention window, Krainer Adrian R. bought $0 and sold $3.9M based on SEC Form 4 filings.
What was Krainer Adrian R.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 33,243 STOK shares on 2026-03-10, worth $1.3M, per SEC Form 4 filings.